Black Rock Inc. Summit Therapeutics Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,898,585 shares of SMMT stock, worth $159 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,898,585

Previous 9,823,341 19.59%

Holding current value

$159 Million

Previous $40.7 Million 51.49%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.39 - $10.92 $4.6 Million - $21 Million	-1,924,756 Reduced 19.59%	7,898,585 $61.6 Million
Q1 2024 May 10, 2024	BUY	$2.55 - $5.07 $163,092 - $324,267	63,958 Added 0.66%	9,823,341 $40.7 Million
Q4 2023 Feb 13, 2024	BUY	$1.67 - $2.83 $1.31 Million - $2.21 Million	782,464 Added 8.72%	9,759,383 $25.5 Million
Q3 2023 Nov 13, 2023	BUY	$1.54 - $2.42 $329,680 - $518,068	214,078 Added 2.44%	8,976,919 $16.8 Million
Q2 2023 Aug 11, 2023	BUY	$1.32 - $2.81 $9.13 Million - $19.4 Million	6,917,788 Added 374.94%	8,762,841 $22 Million
Q1 2023 May 12, 2023	BUY	$1.38 - $5.41 $1.81 Million - $7.09 Million	1,310,393 Added 245.09%	1,845,053 $3.23 Million
Q4 2022 Feb 13, 2023	BUY	$0.68 - $5.31 $77,230 - $603,077	113,574 Added 26.97%	534,660 $2.27 Million
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.63 $105,801 - $193,771	118,878 Added 39.34%	421,086 $500,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $977,946 - $2.53 Million	-1,062,985 Reduced 77.86%	302,208 $302,000
Q1 2022 May 12, 2022	SELL	$2.0 - $3.45 $71,094 - $122,637	-35,547 Reduced 2.54%	1,365,193 $3.34 Million
Q4 2021 Feb 10, 2022	BUY	$2.45 - $5.64 $490,367 - $1.13 Million	200,150 Added 16.67%	1,400,740 $3.77 Million
Q3 2021 Nov 09, 2021	BUY	$4.83 - $8.27 $509,289 - $872,013	105,443 Added 9.63%	1,200,590 $6.02 Million
Q2 2021 Aug 11, 2021	BUY	$5.15 - $8.46 $5.64 Million - $9.26 Million	1,095,147 New	1,095,147 $8.17 Million

Others Institutions Holding SMMT

# of Institutions

213

Shares Held

76.8M

Call Options Held

2.2M

Put Options Held

3.1M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.05B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account